Loading
H(
HUTCHMED (China) Ltd. Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by CHENG Chig Fung Johnny, was filed 22 May 2026.
Insider Decl.
77
Thresholds
n/a
Buy Volume
n/a
21 ops. · all time
Sell Volume
€4M
5 ops. · all time
Who traded when
BuySaleSU Weiguo3 buys2 sales
CHENG Chig Fung Johnny2 buys
Fundamental score
Ranked 14,019 of 26,289 companies
49.5
score / 100
Value30
Quality70
FCF yld-0.5%
Earn yld2.4%
EV/EBITDA37.8x
ROE1.5%
Gross mgn39%
Net mgn83%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$22.28
Analyst consensus
15 analysts1.24/5
HK$21.31Target HK$32.70(+47%)HK$51.95
Income statement
RevenueHK$548.5M
Gross profitHK$212.2M39% margin
EBITDAHK$514.9M94% margin
Net incomeHK$456.9M3.3% margin
Valuation
PER (trailing)139.3x
PER (forward)257.5x
P/Book2.0x
Beta0.36
Balance sheet & cash
Market capHK$19.4B
Total debtHK$97.9M
Free Cash Flow-HK$88.8M
Debt / Equity7%
Profitability & ownership
ROE1.5%
ROA-1.2%
% insiders38.8%
% institutions20.2%
Last declaration on 22 May 2026
Declarations77 total
56,464 shares0ShareXHKGHKEX:DA20260521E00390
Canonical exit: 18 Aug 2026 (T+90)
208,004 shares0ShareXHKGHKEX:DA20260521E00352
Canonical exit: 18 Aug 2026 (T+90)
19,913 shares0ShareXHKGHKEX:DA20260316E00249
524,079 shares0ShareXHKGHKEX:DA20260311E00234
202,238 shares0ShareXHKGHKEX:DA20260311E00239
1,359,561 shares0ShareXHKGHKEX:DA20260306E00315
9,690 sharesShareXHKGHKEX:DA20251021E00345
9,690 sharesShareXHKGHKEX:DA20251021E00353
169,977 shares0ShareXHKGHKEX:DA20250612E00329
Canonical exit: 7 Sept 2025 (T+90)
38,567 shares0ShareXHKGHKEX:DA20250612E00331
Canonical exit: 7 Sept 2025 (T+90)
1,493,435 shares0ShareXHKGHKEX:DA20250612E00340
Canonical exit: 7 Sept 2025 (T+90)
861,220 sharesShareXHKGHKEX:DA20250320E00235
19,913 shares0ShareXHKGHKEX:DA20250317E00207
8,235 sharesShareXHKGHKEX:DA20241022E00501
9,690 sharesShareXHKGHKEX:DA20241022E00492
9,690 sharesShareXHKGHKEX:DA20241022E00502
9,690 sharesShareXHKGHKEX:DA20241022E00503
1,405,767 shares0ShareXHKGHKEX:DA20240807E00242
Canonical exit: 3 Nov 2024 (T+90)
202,238 shares0ShareXHKGHKEX:DA20240531E00460
Canonical exit: 28 Aug 2024 (T+90)
524,079 shares0ShareXHKGHKEX:DA20240531E00463
Canonical exit: 28 Aug 2024 (T+90)
79,652 shares0ShareXHKGHKEX:DA20240531E00453
Canonical exit: 28 Aug 2024 (T+90)
16,000 sharesShareXHKGHKEX:DA20240513E00290
10,190 sharesShareXHKGHKEX:DA20240423E00398
11,985 sharesShareXHKGHKEX:DA20240423E00384
11,985 sharesShareXHKGHKEX:DA20240423E00404
25 of 77 declarations
About HUTCHMED (China) Ltd.
HUTCHMED (China) Ltd. is a Hong Kong healthcare company worth HKD 19.4 billion, of which insiders hold 38.8% of the capital. Its record has 77 filings from 11 filers, with 21 purchases, 5 sales and 51 filings of another kind, so 81% of open-market trades are purchases. No purchase carries an amount; only 2 sales do.
Those two sales come from CHENG Chig Fung Johnny, a director: EUR 2,681,654 on March 7, 2023 and EUR 1,533,730 on March 8, 2023, for EUR 4,215,384 in total. CHENG Chig Fung Johnny has 13 filings, including 6 purchases and 2 sales. SU Weiguo, a director, is the most frequent with 20 filings, 10 of them purchases and 2 sales. ELDAR Dan and MOK Shu Kam Tony, also directors, each lodged 9 filings, including 1 purchase.
Read moreShow less
On October 28, 2021, five insiders filed on the same day. Volume is 16 a year from 2021 to 2024, then 7 in 2025 and 6 in 2026. The median publication delay is 3 days. Over the last twelve months: 6 filings, 2 purchases and 1 sale.
